Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0000899243-21-041580

10% owner bought 250,000 shares at $16.00 ($4,000,000)

  • 10% owner acquired 1,191,444 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RiverVest Venture Fund IV, L.P. 10% owner 2021-10-26 Conversion +832,120 832,120 I: show line 1 in the form
RiverVest Venture Fund IV, L.P. 10% owner 2021-10-26 Conversion +359,324 1,191,444 I: show line 2 in the form
RiverVest Venture Fund IV, L.P. 10% owner 2021-10-26 Purchase +250,000 $16.00 $4,000,000 1,441,444 I: show line 3 in the form
Open-market purchases · 250,000 sh · avg $16.00 · $4,000,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
RiverVest Venture Fund IV, L.P. 10% owner 2021-10-26 Conversion · Series B Preferred Stock −832,120 0 I: show line 4 in the form
RiverVest Venture Fund IV, L.P. 10% owner 2021-10-26 Conversion · Series B Preferred Stock −359,324 0 I: show line 5 in the form
Loading xslF345X03/doc4.xml…